TOVX

Theriva Biologics Inc

$0.25

+0.01 (+5.56%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$7.00
(+2693.3%)
Strong Buy: 0
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0
Description:
Theriva Biologics Inc. (TOVX) is a clinical-stage biotechnology firm based in Rockville, Maryland, committed to tackling critical unmet medical needs through innovative biologic therapies. Leveraging its proprietary technology platforms, the company is focused on developing targeted treatment solutions that aim to improve patient outcomes across multiple therapeutic areas. With a solid pipeline of promising candidates and a highly experienced team, Theriva is strategically positioned to advance its novel therapies and significantly impact the healthcare sector.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, UNITED STATES, 20850
Fiscal year end:
December
Market capitalization:
$8.46 Million
EBITDA:
-$26.3 Million
PERatio:
0.122
EPS:
2.06
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
0.335

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-100%
How much will you get:
$0
Prices dates:
30-10-2015: $20,037.50 and 31-10-2025: $0.31